An Integrative Review of the Relationship Between Intrauterine Devices and Bacterial Vaginosis

Nurs Womens Health. 2023 Apr;27(2):141-151. doi: 10.1016/j.nwh.2023.01.007. Epub 2023 Feb 18.

Abstract

Objective: To examine the relationship between intrauterine devices (IUDs) and bacterial vaginosis (BV) through an integrative review of the current literature.

Data sources: CINAHL, MEDLINE, Health Source, Evidence-Based Medicine's Cochrane Central Registry of Controlled Trials, Embase, and Web of Science databases were searched.

Study selection: Cross-sectional, case-control, cohort, quasi-experimental, and randomized controlled trials examining copper (Cu-IUD) and levonorgestrel (LNG-IUD) use in reproductive- age users with BV occurrence confirmed with Amsel's criteria or Nugent scoring were included. Articles included were published in the past 10 years.

Data extraction: Fifteen studies met criteria, after an initial search identified 1,140 potential titles, and two reviewers assessed 62 full-text articles for inclusion.

Data synthesis: Data were categorized into three groups: retrospective descriptive cross-sectional studies identifying point prevalence of BV among IUD users; prospective analytic studies examining BV incidence and prevalence among Cu-IUD users; and prospective analytic studies examining BV incidence and prevalence among LNG-IUD users.

Conclusion: Synthesis and comparison of studies were difficult because of disparate study designs, sample sizes, comparator groups, and inclusion criteria for individual studies. Synthesis of data from cross-sectional studies showed that all IUD users combined may have an increased point prevalence of BV compared with non-IUD users. These studies did not delineate LNG-IUDs from Cu-IUDs. Findings from cohort and experimental studies suggest a possible increase in BV occurrence among Cu-IUD users. Evidence is lacking to show an association between LNG-IUD use and BV.

Keywords: IUD; bacterial vaginosis; copper IUD; dysbiosis; hormone-releasing IUD; intrauterine device; microbial community; microbiome; vaginal microbiota.

Publication types

  • Review

MeSH terms

  • Contraceptive Agents, Female*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Intrauterine Devices* / adverse effects
  • Intrauterine Devices, Copper* / adverse effects
  • Intrauterine Devices, Medicated*
  • Levonorgestrel / therapeutic use
  • Prospective Studies
  • Retrospective Studies
  • Vaginosis, Bacterial* / epidemiology

Substances

  • Levonorgestrel
  • Contraceptive Agents, Female